-
1 Comment
Kilroy Realty Corporation is currently in a long term uptrend where the price is trading 12.0% above its 200 day moving average.
From a valuation standpoint, the stock is 30.0% more expensive than other stocks from the Real Estate sector with a price to sales ratio of 8.4.
Kilroy Realty Corporation's total revenue rose by 4.1% to $229M since the same quarter in the previous year.
Its net income has increased by 8.5% to $79M since the same quarter in the previous year.
Finally, its free cash flow grew by 7.6% to $92M since the same quarter in the previous year.
Based on the above factors, Kilroy Realty Corporation gets an overall score of 4/5.
Sector | Real Estate |
---|---|
Industry | REIT - Office |
Exchange | F |
CurrencyCode | EUR |
ISIN | US49427F1084 |
Market Cap | 3B |
---|---|
PE Ratio | 18.33 |
Target Price | 78.07 |
Dividend Yield | 6.9% |
Beta | 1.06 |
Kilroy Realty Corporation (NYSE: KRC, the "Company", "Kilroy") is a leading U.S. landlord and developer, with operations in San Diego, Los Angeles, the San Francisco Bay Area, Seattle, and Austin. The Company has earned global recognition for sustainability, building operations, innovation, and design. As a pioneer and innovator in the creation of a more sustainable real estate industry, the Company's approach to modern business environments helps drive creativity and productivity for some of the world's leading technology, entertainment, life science, and business services companies. The Company is a publicly traded real estate investment trust ("REIT") and member of the S&P MidCap 400 Index with more than seven decades of experience developing, acquiring, and managing office, life science, and mixed-use projects. As of June 30, 2024, Kilroy's stabilized portfolio totaled approximately 17.0 million square feet of primarily office and life science space that was 83.7% occupied and 85.4% leased. The Company also had approximately 1,000 residential units in Hollywood and San Diego, which had a quarterly average occupancy of 92.8%. In addition, the Company had two in-process life science redevelopment projects totaling approximately 100,000 square feet with total estimated redevelopment costs of $80.0 million, and one approximately 875,000 square foot in-process development project with a total estimated investment of $1.0 billion.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for KRC.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025